Search Results 1531-1540 of 19960 for Receptor
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...
Erismodegib binds to the Hh cell surface receptor Smo, which may result in the suppression of the Hh signaling pathway and the inhibition of cancer cells.
Unstable dose of SGLT-2 inhibitor, GLP-1 receptor agonist, or other adjuvant medication or starting a new glucose lowering agent during the trial. Unstable ...
... receptor modulator, or SERM, that's approved for treating painful intercourse associated with GSM. While this medication is an option for most women, it isn ...
Brand Award: Disruption in Peroxisome Proliferator-Activated Receptor-? (PPARG) Increases Osteonecrosis Risk Through Genetic Variance and Pharmacologic ...
This lowers their risk of developing COVID-19 because smoking increase receptor sites for COVID-19 to enter cells. Smoking also damages lung tissues, making ...
... receptor-. Cancer. Mayo Clinic Q and A: New blood cancer treatment options with chimeric antigen receptor-T cell therapy. Cynthia Weiss. July 30, 2020. Mayo ...
These treatments pair an antibody that targets cancer cells with a strong chemotherapy drug. For many patients with human epidermal growth factor receptor 2- ...
GTx-024 is an orally bioavailable and tissue-selective nonsteroidal selective androgen receptor modulator (SARM) that has demonstrated androgenic and ...
Olmesartan is an angiotensin II receptor blocker (ARB). It works by blocking a substance in the body that causes the blood vessels to tighten. As a result ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.